与黑人种族身份或非洲血统个体中创伤性脑损伤结局相关的分子生物标志物:一篇叙述性综述
本文为叙述性综述,通过PubMed检索纳入专门考察种族、族裔或血统与创伤性脑损伤(TBI)结局相关分子生物标志物的研究。多数研究聚焦血液或脑脊液来源的蛋白标志物,发现S100β、泛素C端水解酶L1、β-淀粉样蛋白和tau在参与者种族间存在统计学变异;部分研究还发现载脂蛋白E、ANKK1和COMT多态性与TBI结局相关,且等位基因频率随人群血统存在变异。作者指出种族和血统对TBI结局相关生物标志物的作用仍不确定,尚需后续工作。
要点
- 多数研究聚焦血液或脑脊液来源的蛋白生物标志物与TBI结局的关系。
- S100β、泛素C端水解酶L1、β-淀粉样蛋白和tau在参与者种族间存在统计学变异。
- 载脂蛋白E、ANKK1和COMT多态性与TBI结局相关,等位基因频率随人群血统存在变异。
核心结论
- 种族和血统对TBI结局相关生物标志物的作用仍不确定,尚需后续工作以理解其对TBI患者的含义。
研究设计与样本
- 叙述性综述,通过PubMed文献检索纳入考察黑人种族身份或非洲血统参与者中与TBI结局相关的分子生物标志物的研究。
主要发现
- 多数纳入研究聚焦血液或脑脊液来源的蛋白生物标志物。
- 研究发现在基线或TBI后,S100β、泛素C端水解酶L1、β-淀粉样蛋白和tau在参与者种族间存在统计学变异。
- 若干研究发现载脂蛋白E、ANKK1和COMT多态性与TBI结局相关,并发现等位基因频率随人群血统存在变异。
局限性
- 当代研究议程在很大程度上忽视或排除了黑人群体,导致黑人患者群体在TBI研究中持续被边缘化,限制了正在进行的研究对美国及全球患者的普遍性。
- 种族和血统对TBI结局相关生物标志物的作用仍不确定,尚需后续工作。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Traumatic brain injury (TBI) is a leading cause of death and disability worldwide and a major global health concern. In the United States, individuals of Black or African American racial identity experience disproportionately higher rates of TBI and suffer from worse postinjury outcomes. Contemporary research agendas have largely overlooked or excluded Black populations, resulting in the continued marginalization of Black patient populations in TBI studies, thereby limiting the generalizability of ongoing research to patients in the United States and around the world. This review aims to highlight what is currently known, and identify knowledge gaps, in research on molecular biomarkers associated with TBI in Black populations. A PubMed literature search was conducted to identify studies that investigate molecular biomarkers associated with TBI outcomes that include participants of Black racial identity and those of African ancestry. Studies identified for this review investigate biomarkers associated with TBI outcomes through a lens that specifically examines race, ethnicity, or ancestry. Most studies focused on blood- or cerebrospinal fluid-derived protein biomarkers. Studies identified statistical variation in S100ß, ubiquitin C-terminal hydrolase-L1, amyloid-ß, and tau across participant race, either at baseline or following TBI. Additionally, several studies identified genetic polymorphisms associated with TBI outcomes related to apolipoprotein E, ANKK1, and COMT polymorphism and TBI outcome and identified allele frequency variation across population ancestry. The role of race and ancestry on biomarkers associated with TBI outcome remains indeterminate and subsequent work is still required to understand the implications for patients with TBI.
引用
- Wroblewski TH, Ajmal E, Ononogbu-Uche F, et al. Molecular Biomarkers Associated with Traumatic Brain Injury Outcome in Individuals of Black Racial Identity or African Ancestry: A Narrative Review. World Neurosurg. 2025. PMID: 39732452. doi:10.1016/j.wneu.2024.123620
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。